Skip to content

Bruce Ladenheim

National Institute on Drug Abuse

3 papers in the library · 165 citations · publishing 1995-2002

Papers

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice

Synapse October 1, 1995 Jean Lud Cadet, Bruce Ladenheim, Hiroshi Hirata et al. 81 citations

Mice carrying extra copies of the human superoxide dismutase gene are protected against MDMA-induced damage to brain dopamine neurons. Normal mice showed large drops in striatal dopamine and its metabolite DOPAC one day and two weeks after a single MDMA injection. Mice with one copy of the transgene showed dopamine loss only at one day, while mice with two copies showed no loss at either time point. Three repeated injections caused dopamine loss in normal mice, small losses in one-copy mice, and no loss in two-copy mice. Serotonin levels were unaffected in all groups. The findings indicate that superoxide radicals contribute to MDMA's dopamine toxicity.

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

Brain Research September 1, 1997 Hema Mann, Bruce Ladenheim, Hiroshi Hirata et al. 50 citations

Methamphetamine (METH) and MDMA affect dopamine systems differently depending on the presence of P-glycoproteins, which regulate entry into the brain via the blood-brain barrier. In mice lacking the mdr1a gene (knockout), low doses of METH (2.5 mg/kg) caused marked decreases in dopamine and dopamine transporters in the striatum and nucleus accumbens, whereas wild-type mice showed only small changes. Higher METH doses produced similar effects in both strains. Conversely, MDMA caused greater percentage decreases in dopamine transporters in wild-type mice, with the lowest dose (5 mg/kg) significantly reducing transporters in the nucleus accumbens of wild-type but not knockout mice. These findings indicate that P-glycoproteins may facilitate MDMA entry into the brain but interfere with METH entry.

Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex

The FASEB Journal December 1, 2002 Bruce Ladenheim, Michael Mccoy, Jean Lud Cadet et al. 34 citations

MDMA (ecstasy) triggers changes in gene activity in the rat cortex within hours of a single injection. The genes affected are involved in signaling, transcription regulation, and xenobiotic metabolism, suggesting that the cortex responds acutely by altering transcription of genes that could lead to long-term brain changes. MDMA is known to cause hyperthermia, reactive oxygen species, and long-term serotonin depletion, with the cortex especially sensitive. These molecular changes may underlie the drug's lasting effects on the brain.